Trial of the Oral PCSK9 Inhibitor Enlicitide

A Wed, study studied this question.

www.synapsesocial.com/papers/69fcad6394e0b6d26aa0375a — DOI: https://doi.org/10.1056/nejmc2602975

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. Comparison of a Novel Method vs the Friedewald Equation for Estimating Low-Density Lipoprotein Cholesterol Levels From the Standard Lipid Profile· 2013 · 841 citations
2. The Prevention and Treatment of Missing Data in Clinical Trials· 2012 · 1,875 citations
3. Prevalence and determinants of adherence to statin therapy: a systematic review and meta-analysis· 2025 · 3 citations
4. Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease